Literature DB >> 12700323

Early or late appearance of "dropped head syndrome" in amyotrophic lateral sclerosis.

M Gourie-Devi1, A Nalini, S Sandhya.   

Abstract

BACKGROUND: "Dropped head syndrome" caused by neck extensor weakness has been reported in a variety of neuromuscular disorders. Previously published reports include isolated cases with amyotrophic lateral sclerosis (ALS). In this report, nine patients with ALS and dropped head syndrome seen during a 20 year period are described. PATIENTS AND INVESTIGATIONS: Between 1981 and 2000, 683 patients with ALS were diagnosed, based on El Escorial criteria. Nine of these had profound neck extensor weakness observed as an early feature, or developing during the later stages of the disease. The protocol for evaluation included detailed clinical history, neurological examination, electromyography, and nerve conduction studies. Investigations were undertaken to exclude malignancy, lymphoproliferative disorders, thyroid dysfunction, and collagen vascular disease.
RESULTS: The incidence of dropped head syndrome was 1.3%. The mean (SD) age of the affected patients was 53.3 (10.3) years (range 33 to 65), with an equal distribution of cases in the fourth to seventh decades. In six patients, head drop was an early feature (mean interval from onset of illness 11.6 months (range 3 to 24)); in three it was late (between three and eight years after onset). In five patients, mild neck flexor weakness was present in addition to severe extensor weakness. In all nine patients there were diffuse upper and lower motor neurone signs. None of the patients had difficulty in breathing but all had difficulty in swallowing and social embarrassment, both of which could be corrected by simple measures.
CONCLUSIONS: Dropped head syndrome is an important clinical sign and usually occurs as an early feature within the first one to two years after the onset of ALS. The cause of dropped head syndrome in these nine cases could be easily established as ALS by the presence of generalised signs.

Entities:  

Mesh:

Year:  2003        PMID: 12700323      PMCID: PMC1738454          DOI: 10.1136/jnnp.74.5.683

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

Review 1.  The phenotypic variability of amyotrophic lateral sclerosis.

Authors:  Bart Swinnen; Wim Robberecht
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

2.  Intralingual Administration of AAVrh10-miRSOD1 Improves Respiratory But Not Swallowing Function in a Superoxide Dismutase-1 Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Lori A Lind; Ellyn M Andel; Angela L McCall; Justin S Dhindsa; Katherine A Johnson; Olivia E Stricklin; Christian Mueller; Mai K ElMallah; Teresa E Lever; Nicole L Nichols
Journal:  Hum Gene Ther       Date:  2020-07-13       Impact factor: 5.695

Review 3.  Biological Spectrum of Amyotrophic Lateral Sclerosis Prions.

Authors:  Magdalini Polymenidou; Don W Cleveland
Journal:  Cold Spring Harb Perspect Med       Date:  2017-11-01       Impact factor: 6.915

4.  Hypoglossal Motor Neuron Death Via Intralingual CTB-saporin (CTB-SAP) Injections Mimic Aspects of Amyotrophic Lateral Sclerosis (ALS) Related to Dysphagia.

Authors:  Lori A Lind; Erika R Murphy; Teresa E Lever; Nicole L Nichols
Journal:  Neuroscience       Date:  2018-09-01       Impact factor: 3.590

Review 5.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

Review 6.  Camptocormia in Parkinson's disease.

Authors:  Eldad Melamed; Ruth Djaldetti
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

7.  Dropped head with positive intravenous edrophonium, progressing to myasthenia gravis.

Authors:  Nobuhiro Sawa; Hiroshi Kataoka; Nobuyuki Eura; Satoshi Ueno
Journal:  BMJ Case Rep       Date:  2013-01-31

8.  Effect of fluoxetine on disease progression in a mouse model of ALS.

Authors:  J E Koschnitzky; K A Quinlan; T J Lukas; E Kajtaz; E J Kocevar; W F Mayers; T Siddique; C J Heckman
Journal:  J Neurophysiol       Date:  2014-03-05       Impact factor: 2.714

9.  Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort.

Authors:  N Ticozzi; V Silani; A L LeClerc; P Keagle; C Gellera; A Ratti; F Taroni; T J Kwiatkowski; D M McKenna-Yasek; P C Sapp; R H Brown; J E Landers
Journal:  Neurology       Date:  2009-09-09       Impact factor: 9.910

10.  Dropped head syndrome: diagnosis and management.

Authors:  Allan R Martin; Rajesh Reddy; Michael G Fehlings
Journal:  Evid Based Spine Care J       Date:  2011-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.